+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leukemia Drugs Market Research Reports

Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • January 2023
  • 36 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • January 2023
  • 33 Pages
  • Global
From
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • January 2023
  • 35 Pages
  • Global
From
Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 34 Pages
  • Global
From
US Acute Myeloid Leukemia Market to 2028 - Product Thumbnail Image

US Acute Myeloid Leukemia Market to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Myelofibrosis Treatment Market by Type, Distribution Channel, and Geography: Forecast up to 2027 - Product Thumbnail Image

Myelofibrosis Treatment Market by Type, Distribution Channel, and Geography: Forecast up to 2027

  • Report
  • July 2023
  • 172 Pages
  • Global
From
CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028 - Product Thumbnail Image

CAR T-Cell Therapy Market, By Type (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta), End-user (Hospitals, Specialty Clinics, Others), Application (Cancer, Lymphoma, Others), Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2028

  • Report
  • June 2022
  • 220 Pages
  • Global
From
Disease Analysis: Acute Myeloid Leukemia (AML) - Product Thumbnail Image

Disease Analysis: Acute Myeloid Leukemia (AML)

  • Report
  • April 2021
  • 120 Pages
  • Global
Market Spotlight: Myelodysplastic Syndrome (MDS) - Product Thumbnail Image

Market Spotlight: Myelodysplastic Syndrome (MDS)

  • Report
  • February 2021
  • 60 Pages
  • Global
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Kymriah - Product Thumbnail Image

Kymriah

  • Report
  • January 2019
  • 38 Pages
  • Global
From
Venclexta - Product Thumbnail Image

Venclexta

  • Report
  • January 2019
  • 45 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Imbruvica - Product Thumbnail Image

Imbruvica

  • Report
  • January 2019
  • 51 Pages
  • Global
From
Pomalyst - Product Thumbnail Image

Pomalyst

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Kyprolis - Product Thumbnail Image

Kyprolis

  • Report
  • August 2018
  • 36 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1182 Pages
  • Global
From
Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 504 Pages
  • Global
From
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 232 Pages
  • Global
From
Loading Indicator

The Leukemia Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat leukemia, a type of cancer of the blood and bone marrow. These drugs are used to reduce the number of cancer cells in the body, and to prevent the spread of the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells, and immunotherapy is a type of drug that works by stimulating the body's immune system to fight cancer cells. The Leukemia Drugs market is highly competitive, with many companies competing for market share. Some of the major players in the market include Novartis, Pfizer, Bristol-Myers Squibb, Celgene, and Amgen. Show Less Read more